Veru Inc. (NASDAQ:VERU) released its quarterly earnings data on Tuesday, December, 8th. WARNING: Trend forecast is still in the development phase and should be used with caution. 4 brokerages have issued 12-month target prices for Veru's stock. Tuesday, March 19, 2019. Sign Up. Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. Vir Biotechnology Inc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. Cancel. Standard & Poor's and S&P are registered trademarks of Standard & Poor's Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. It is usually referred to as NASDAQ:VERU or VERU-Q Is Veru a buy or a sell? Should I buy or sell VERU? Short-term (time horizon: 2 weeks) VERU INC share price prediction for 2021-01-27 with daily closed price projections The consensus among Wall Street analysts is that investors should "buy" Veru stock. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. 0 analysts have rated the stock as a Sell or Underperform. Veru Inc. (VERU) Analyst Forecasts Analyst recommendations provided by FactSet shows that the consensus forecast for Veru Inc. (VERU) is a “Buy”. France. Find the latest Veru Inc. (VERU) stock discussion in Yahoo Finance's forum. Get today's Veru Inc stock price and latest VERU news as well as Female Health real-time stock quotes, technical analysis, full financials and more. View analyst ratings for Veru or view MarketBeat's top 5 stock picks. Veru started at outperform with $5 stock price target at Oppenheimer MarketWatch. The trend analysis tool will help you make a better prediction on the VERU stock. The VERU stock … There are currently 4 buy ratings for the stock. Veru Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. Veru's stock soars again on heavy volume after positive results of breast cancer treatment MarketWatch. The company reported $0.03 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of ($0.04) by $0.07. Analysts have given the company’s stock an average 52-week price target of $7.67, forecast between a low of $6 and high of $9. Veru's earnings in 2020 is -$18,973,535.On average, 4 Wall Street analysts forecast VERU's earnings for 2021 to be $-16,941,943, with the lowest VERU earnings forecast at $-29,342 Monday, December 14, 2020. With a 5-year investment, the revenue is expected to be around +32.62%. Monday, December 14, 2020. Top Analysts. Disclaimer. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings. Do Not Sell My Information. Earnings for Veru are expected to decrease in the coming year, from ($0.16) to ($0.26) per share. Veru Inc. 9.76 0.21 (2.20%) Watch. © 2020 Cable News Network. Veru trades on the NASDAQ under the ticker symbol "VERU.". NASDAQ: VERU has surged by over 50% on Monday, extending its gains. Their forecasts range from $8.00 to $19.00. Since then, VERU stock has increased by 179.1% and is now trading at $8.93. It considers technical and fundamental factors and is a good starting point for evaluating a stock. Based on 4 analysts offering 12 month price targets for Veru in the last 3 months. Results. Showing: All Analyst Consensus & Price Target. New customer. Who this matters to: Overall Ranking is a comprehensive evaluation. The stock is rated as a Hold by none analyst(s), 4 recommend it as a Buy and no body called the VERU stock Outperform. To see all exchange delays and terms of use please see disclaimer. For long-term investors, stocks are a good investment even during periods of the market volatility - a stock market downturn means that many stocks are on sale. All times are ET. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. The company, currently valued at $634.88 Million, closed the last trade at $9.06 per share which meant it gained $0.39 on the day or 4.5% during that session. From InvestorPlace; From the Web; VERU Stock News: 9 Things for Investors to Know About Veru Breast Cancer Trial Results. All rights reserved. Investing in stocks, such as Veru, is an excellent way to grow wealth. Veru Inc. was incorporated in 1971 and is headquartered in Miami, Florida. Sign up. Identify stocks that meet your criteria using seven unique stock screeners. Do Options Traders Know Something About Veru (VERU) Stock We Don't? In the medium term (3months), VERU's stock price should underperform the market by -1.36%. Their average twelve-month price target is $14.75, predicting that the stock has a possible upside of 50.97%. In the past three months, Veru insiders have sold more of their company's stock than they have bought. 08:13 AM ET. View Veru's Short Interest. Its customers primarily include international agencies, government health agencies, ministries of health, and other governmental agencies, which purchase and distribute FC2 for use in HIV/AIDS prevention and family planning programs; and telemedicine providers who sell into the prescription channel in the United States. ET by Tomi Kilgore. Log in. Veru Inc. (NASDAQ:VERU) has a beta value of 0.43 and has seen 2,412,348 shares traded in the last trading session. Veru stock price target raised to $19 from $9 at Oppenheimer MarketWatch. Best Performing Analyst Consensus & Price Target Premium. Veru Inc. (VERU) estimates and forecasts. Veru stock price target raised to $19 from $9 at Oppenheimer. Only 23.13% of the stock of Veru is held by institutions. The Commercial segment consists of FC2. Dec. 16, 2020 at 8:13 a.m. Find market predictions, VERU financials and market news. Trending now . Based on our forecasts, a long-term increase is expected, the "VERU" stock price prognosis for 2025-12-30 is 12.228 USD. More. VERU Stock Forecast - Get a free VERU stock predictions and find out whether you should buy or sell VERU stock. Veru's stock soars again on heavy volume after positive results of breast cancer treatment MarketWatch. Veru had a negative net margin of 25.78% and a negative return on equity of 30.37%. ... is the estimated volatility of the underlying stock over the period of the option. Analyst recommendations provided by FactSet shows that the consensus forecast for Veru Inc. (VERU) is a “Buy”. Investors need to pay close attention to Veru (VERU) stock based on the movements … This NYC Startup Raises $51M to Disrupt the Retirement Industry, 5 Social Security Mistakes to Avoid At All Costs, 7 Mistakes That Will Ruin Your Retirement Income, 7 Retirement Secrets Smart Americans Should Know, You Can Still Buy This "Millionaire Maker" Stock, Bitcoin Up 30,000X -- Here's Your Backdoor In, This Stock Could Be Like Buying Amazon for $3.19. Their average twelve-month price target is $14.75, predicting that the stock has a possible upside of 50.97%. The average price target represents a 78.79% upside from the last price of $8.25. Tech. The company earns $-12,020,000.00 in net income (profit) each year or ($0.19) on an earnings per share basis. In the last year, 1 stock analyst published opinions about VERU-Q. Veru story: Should you continue to rely on Veru NASDAQ VERU management and other headlines for Veru Inc Stock You may vote once every thirty days. Based on aggregate information from My MarketBeat watchlists, some companies that other Veru investors own include (KDMN), Sorrento Therapeutics (SRNE), ADMA Biologics (ADMA), Corbus Pharmaceuticals (CRBP), Matinas BioPharma (MTNB), OrganiGram (OGI), Vaxart (VXRT), Rigel Pharmaceuticals (RIGL), SCYNEXIS (SCYX) and VBI Vaccines (VBIV). Discover our services. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. As of December 31st, there was short interest totaling 2,040,000 shares, an increase of 51.1% from the December 15th total of 1,350,000 shares. Export data to Excel for your own analysis. One share of VERU stock can currently be purchased for approximately $8.93. This suggests a possible upside of 65.2% from the stock's current price. Webull offers VERU (VERU) historical stock prices, in-depth market analysis, NASDAQ: VERU real-time stock quote data, in-depth charts, and a fully built financial calendar to help you invest smart. Given the current short-term trend, the stock is expected to rise 224.27% during the next 3 months and, with a 90% probability hold a price between $19.64 and $38.90 at the end of this 3-month period. Veru has a market capitalization of $625.77 million and generates $31.80 million in revenue each year. Sign up. In the meantime, none analyst(s) believe the stock as Underperform and none think it is a Sell. The average price target is $14.75, with a high forecast of $19.00 and a low forecast of $8.00. The post VERU Stock News: 9 Things for Investors to Know About... Zacks Investment Research - 4 weeks ago. veru $9.76 $0.21 2.2% Price as of January 11, 2021, 9:00 p.m. EST View Interactive VERU Charts Woodseer Dividend … The official website for Veru is www.veruhealthcare.com. All rights reserved. Get short term trading ideas from the MarketBeat Idea Engine. Analyst Future Growth Forecasts. The average price target is $29.67 with a high forecast of $32.00 and a low forecast of $27.00.The average price target represents a 148.08% increase from the last price of $11.96. About the Veru, Inc. stock forecast As of 2021 January 11, Mondaycurrent price of VERUstock is 9.560$and our data indicates that the asset price has been stagnating for the past 1 year (or since its inception). Past Monthly Recommendations. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Veru does not have a long track record of dividend growth. Log In. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Fundamental company data provided by Morningstar and Zacks Investment Research. Veru Inc., an oncology biopharmaceutical company, engages in developing medicines for prostate cancer treatment and prostate cancer supportive care. Further, Veru Inc. (VERU) has a beta value of 0.29, and an average true range (ATR) of 0.47. Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. MarketBeat just released five new trading ideas, but Veru wasn't one of them. AC Investment Inc. delivers machine learning based share price forecast. During the day the stock fluctuated 3.55% from a day low at $8.45 to a day high of $8.75. AC Investment Inc. delivers machine learning based share price forecast. 4 Wall Street analysts have issued ratings and price targets for Veru in the last 12 months. Want to see which stocks are moving? Learn more. The average price target represents a 67.91% increase from the last price of $9.38. 4 analysts offering their recommendations for the stock have an average rating of 1.70, where 0 rate it as a Hold and 0 think it is a “Overweight”. Veru Inc. (NASDAQ:VERU) has a beta value of 0.43 and has seen 2,412,348 shares traded in the last trading session. The P/E ratio of Veru is -56.06, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Analyst Rating Consensus. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 The company, currently valued at $634.88 Million, closed the last trade at $9.06 per share which meant it gained $0.39 on the day or 4.5% during that session. Veru has received 57.28% “outperform” votes from our community. MarketBeat's community ratings are surveys of what our community members think about Veru and other stocks. Veru's stock soars again on heavy volume after positive results of breast cancer treatment MarketWatch. Context Approach Progress Team Partners. The company was formerly known as The Female Health Company and changed its name to Veru Inc. in July 2017. Receive a free world-class investing education from MarketBeat. What is Veru stock symbol? Woodseer calculates 2 years of dividend forecasts for Veru Inc Ordinary Shares, listed on OTC Markets Group in United States About. 07:25 AM ET. Veru started at outperform with $5 stock price target at Oppenheimer MarketWatch. Schweiz (DE) Suisse (FR) United Kingdom. Skip to content. View which stocks are hot on social media with MarketBeat's trending stocks report. View all of VERU's competitors. Strong Buy. VERU stock is also up 7x from levels of $1 seen in early 2019, two years ago. View live VERU INC chart to track its stock's price action. Based on an average daily volume of 5,860,000 shares, the days-to-cover ratio is currently 0.3 days. Veru stock price target raised to $19 from $9 at Oppenheimer MarketWatch. VERU INC stock price forecast for further price development down to -16.92% (time horizon: 1 day) and price target of 7.90 USD. The VERU stock will be analyzed using Smart Scan and the Trade Triangle technology. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. CNN Sans™ & © 2016 Cable News Network. Some companies that are related to Veru include The Estée Lauder Companies (EL), Herbalife Nutrition (HLF), Nu Skin Enterprises (NUS), Medifast (MED), Inter Parfums (IPAR), Prestige Consumer Healthcare (PBH), USANA Health Sciences (USNA), Revlon (REV) and Nature's Sunshine Products (NATR). Veru started at outperform with $5 stock price target at Oppenheimer MarketWatch. The company earned $11.75 million during the quarter, compared to the consensus estimate of $10.64 million. In the short term (2weeks), VERU's stock price should outperform the market by 0.14%.During that period the price should oscillate between -11.29% and +21.38%.. Detailed list of analyst forecasts MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Please log in to your account or sign up in order to add this asset to your watchlist. Learn everything you need to know about successful options trading with this three-part video course. Factset: FactSet Research Systems Inc.2019. Veru Inc. is estimated to report earnings on 02/10/2021. VERU stock forecast Our latest prediction for Veru, Inc.'s stock price was made on the Aug. 26, 2020 when the stock price was at 2.74$.. An Overall Rank of 90 means that our comprehensive methodology rates Veru Inc above 90% of stocks. Most stock quote data provided by BATS. Veru Inc. is an oncology and urology biopharmaceutical company with a focus on developing medicines for the management of prostate cancer. Positive news sentiment. VERU stock forecast Our latest prediction for Veru, Inc.'s stock price was made on the Aug. 26, 2020 when the stock price was at 2.74$. Find the latest Earnings Report Date for Veru Inc. Common Stock (VERU) at Nasdaq.com. The Company operates in two segments: Commercial and Research, and Development. KushCo: A Cannabis Stock That Could be Fire, Defi Is The Next Generation For Cryptocurrency Investors, Village Farms International (NASDAQ: VFF) Stock is a Unique Cannabis ESG Play, Progress Software (NASDAQ:PRGS) Slips After Weak Guidance, JP Morgan Chase (NYSE:JPM) Is A Buy On Post-Earnings Weakness, Buy Pure Storage (NASDAQ: PSTG) Stock on Pullback Levels Here, Exxon’s (NYSE:XOM) 7% Yield Is A Buy And Hold For 2021, Here’s Where to Buy Dropbox (NASDAQ: DBX) Shares on Pullbacks, 7 Cryptocurrencies That Are Leading The Market Higher, 7 Stocks to Support Your New Year’s Resolutions, 7 Things You Need To Know About Cryptocurrency, 7 Stocks to Buy As Americans Receive Stimulus Checks, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, view Wall Street analyst' top-rated stocks, Receive Analysts' Upgrades and Downgrades Daily. The average price target is $14.75, with a high forecast of $19.00 and a low forecast of $8.00. 4 Wall Street analysts have issued ratings and price targets for Veru in the last 12 months. Learn more. Veru Inc announcement promising Phase 2 results for its breast cancer treatment. Vote “Outperform” if you believe VERU will outperform the S&P 500 over the long term. Its drug candidates also include Zuclomiphene citrate, which has completed Phase II clinical trial for the treatment of hot flashes in men with advanced prostate cancer; VERU-100, a GnRH antagonist that is in planned Phase II clinical trial for the palliative treatment of advanced prostate cancer; Enobosarm, a selective androgen receptor agonist that is in planned Phase III registration study for the treatment of metastatic breast cancer; and TADFYN, a tadalafil and finasteride combination capsules for the treatment of men with lower urinary tract symptoms. Menu. Tuesday, March 19, 2019. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. Additionally, the company's commercial products include the FC2 Female/Internal condoms for the prevention of pregnancy and sexually transmitted infections. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Only 26.10% of the stock of Veru is held by insiders. All times are ET. View our full suite of financial calendars and market data tables, all for free. The Veru Inc. stock price gained 0.58% on the last trading day (Thursday, 31st Dec 2020), rising from $8.60 to $8.65. 02:53 PM ET . How is Veru forecast to perform in the next 1 to 3 years based on estimates from 4 analysts? VERU Stock Predictions. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Deutschland. What this means: Veru Inc (VERU) gets a very positive evaluation from InvestorsObserver's ranking system. Earnings and Revenue Growth Forecasts. The VERU stock price is -26.38% off its 52-week high price of $11.45 and 74.61% above the 52-week low of $2.3. S&P 500 0.00%. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. Sign up for FREE. Find the latest TheVeryGoodFood (VERY.CN) stock discussion in Yahoo Finance's forum. Find real-time VERU - Veru Inc stock quotes, company profile, news and forecasts from CNN Business. Shares of VERU can be purchased through any online brokerage account. The company directors and management may have good odds in positioning the company resources to exploit market volatility in January.The stock standard deviation of daily returns for 30 days investing horizon is currently 9.97. Real-time trade and investing ideas on Veru Inc. VERU from the largest community of traders and investors. Rooms Rankings Earnings Calendar Shop. The Stock Market Forecast. 4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Veru in the last year. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. 100% Free, Limited Time Only! 4 analysts offering their recommendations for the stock have an average rating of 1.70, where 0 rate it as a Hold and 0 think it is a “Overweight”. More VERU Stock Predictions. Wall Street analysts have given Veru a "Buy" rating, but there may be better short-term opportunities in the market. However, the pandemic hasn’t hit the US. Veru has a P/B Ratio of 17.94. Earnings vs Savings Rate: VERU is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2%). As of 2021 January 11, Monday current price of VERU stock is 9.560$ and our data indicates that the asset price has been stagnating for the past 1 year (or since its inception).. Veru, Inc. has been showing a declining tendency so we believe that similar market segments were mildly popular in the given time frame. Veru Inc VERU WideScreen charts, DMA,SMA,EMA technical analysis, forecast prediction, by indicators ADX,MACD,RSI,CCI NASDAQ stock exchange Veru Inc VERU Current Price 21 Oct, 2020 Closed at:2.43 which is -1.62% from previous closing of 2.47 E-mail: Password: Remember: Forgot password ? During that period the price should oscillate between -8.99% and +13.53%. Access to Intraday penny stock screener Scan for strong stocks Never miss a profitable trade. Most stock quote data provided by BATS. Company Releases for Veru Inc. Tuesday, … All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2019 and/or its affiliates. Share your opinion and gain insight from other stock traders and investors. VERU Stock Forecast NASDAQ: VERU is at the upper end of its recent trading range but below the 52-week high of $11.45. Approximately 3.8% of the shares of the company are sold short. Data shows that the Veru Inc. share is performing relatively much better than most of its peers within the same industry. On Dec. 14, Veru stock rose by 52.6 percent, while the S&P 500 lost 0.4 percent. View which stocks have been most impacted by COVID-19. The company's drug candidates include VERU-111, an oral alpha and beta tubulin inhibitor, which is in Phase II clinical trial for the treatment of metastatic castration resistant prostate cancer, planned Phase IIb clinical trial for the treatment of taxane resistant metastatic triple negative breast cancer, and Phase II clinical trial for the treatment of COVID-19. VERU stock is also up 7x from levels of $1 seen in early 2019, two years ago. IV can help traders determine if options are fairly valued, undervalued, or overvalued. The 12-month stock price forecast is 15.75, which is an increase of 61.37% from the latest price. 1 analyst recommended to BUY the stock. Veru's stock was trading at $3.20 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Should I buy or sell VERU stock? Veru Inc. (VERU) estimates and forecasts. DOW 0.00%. 4 analyst(s) have assigned their ratings of the stock’s forecast evaluation on a scale of 1.00-5.00 to indicate a strong buy to a strong sell recommendation. The company’s stock has been forecasted to trade at an average price of $15.75 over the course of the next 52 weeks, with a low of $12 and a high of $19. Zooming out, it has … VERU INC. company earnings calendar and analyst expectations - Upcoming and past events | Nasdaq: VERU | Nasdaq Veru stock price target raised to $19 from $9 at Oppenheimer MarketWatch. Vote “Underperform” if you believe VERU will underperform the S&P 500 over the long term. NASDAQ 0.00%. New member. Veru has only been the subject of 3 research reports in the past 90 days. See what's happening in the market right now with MarketBeat's real-time news feed. On average, they expect Veru's stock price to reach $14.75 in the next year. 02:53 PM ET. Veru's mailing address is 48 NW 25th Street Suite 102, Miami FL, 33127. A rank of 46 means that 54% of stocks appear more favorable to our system. Overview Methodology Accuracy Coverage Sample Data Cancelled Dividends. Veru employs 339 workers across the globe. ), Veru has received 179 “underperform” votes. Real-time trade and investing ideas on Veru Inc. VERU from the largest community of traders and investors. Veru has received a consensus rating of Buy. Tuesday, Mar 19, 2019. The stock has risen $3.34 from its previous closing price of $6.36 on a volume of 134,631,846 shares. All Analysts. In the medium term (3months), VERU's stock price should underperform the market by -3.72%. More. Sign-up to receive the latest news and ratings for VERU and its competitors with MarketBeat's FREE daily newsletter. © American Consumer News, LLC dba MarketBeat® 2010-2021. Forecasted annual earnings growth. Your current $100 investment may be up to $132.62 in 2026. A Warner Media Company. Based on 4 Analyst Ratings. Clients Case Studies. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Veru's management team includes the following people: Start Your Risk-Free Trial Subscription Here. The company can be reached via phone at 305-509-6897 or via email at [email protected]. Veru, Inc.has been showing a declining tendency so we believe that similar market segments were mildly popular in the given time frame. Get Our PREMIUM Forecast … VERU INC. company earnings calendar and analyst expectations - Upcoming and past events | Nasdaq: VERU | Nasdaq. According to analysts' consensus price target of $14.75, Veru has a forecasted upside of 64.4% from its current price of $8.97. So what was a rosy situation as we started 2020, is quickly souring. Delta Air Lines or Southwest Airlines: Which Is a Better Buy As Vaccines Roll Out? Share your opinion and gain insight from other stock traders and investors. The stock has risen $3.34 from its previous closing price of $6.36 on a volume of 134,631,846 shares. View our earnings forecast for Veru. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Product. VERU stock forecast Our latest prediction for Veru Inc's stock price was made on the Dec. 16, 2020 when the stock price was at 9.99$.. Veru Stock Forecast, Price & News How has Veru's stock been impacted by COVID-19? Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. The US economy is still solid and improving, but is it exempt from the virus fallout? Articles Contact LIVE Login. To hit the forecast high, the stock’s price needs a +100.21% upsurge from its current level, while the stock would need to tank 26.45% for it to hit the projected low. Stocks Option prices for Veru Inc with option quotes and option chains. All Rights Reserved. The average price target represents a 78.79% upside from the last price of $8.25. 07:25 AM ET. 4 of the analysts rate the stock as a “Buy”. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Who this matters to: Overall Ranking is a comprehensive evaluation. Veru's stock was trading at $3.20 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. On Dec. 14, Veru stock rose by 52.6 percent, while the S&P 500 lost 0.4 percent. Veru has received 240 “outperform” votes. 60.9%. Specifically, they have bought $0.00 in company stock and sold $3,487,500.00 in company stock. Further, Veru Inc. (VERU) has a beta value of 0.29, and an average true range (ATR) of 0.47. View Veru's earnings history. Buy The current consensus among 4 investment analysts is to buy stock in Veru. VERU stocks are also rising following its revenue increased by 35% to $11.75 million, yet that was insufficient to result in a profit – the firm's net loss rose to $11.8 million. The high price target for VERU is $19.00 and the low price target for VERU is $8.00. XL Fleet (NYSE:XL) Stock: The Next Big EV Company? Get daily stock ideas top-performing Wall Street analysts. What this means: Veru Inc (VERU) gets an Overall Rank of 58, which is an above average rank under InvestorsObserver's stock ranking system. Morningstar: © 2019 Morningstar, Inc. All Rights Reserved. The average price target is $15.75 with a high forecast of $19.00 and a low forecast of $12.00. In the short term (2weeks), VERU's stock price should outperform the market by 3.38%.During that period the price should oscillate between -8.99% and +13.53%.. Veru (VERU) stock is doing well on Monday after announcing positive news from a Phase 2 clinical trial of its breast cancer drug. Veru is a American stock, trading under the symbol VERU-Q on the NASDAQ (VERU). To hit the forecast high, the stock’s price needs a +100.21% upsurge from its current level, while the stock would need to tank 26.45% for it to hit the projected low. Analysts have given the company’s stock an average 52-week price target of $7.67, forecast between a low of $6 and high of $9. Furthermore, Veru Inc. (VERU)’s beta value is 0.63, and its average true range (ATR) is 0.96. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. This price target is based on 4 analysts offering 12 month price targets for Veru in the last 3 months. View analysts' price targets for Veru or view Wall Street analyst' top-rated stocks. Move your mouse over past months for details. 4 Buy; 0 Hold; 0 Sell; Based on 4 Wall Street analysts offering stock ratings for Homology Medicines in the last 3 months (by analysts ranked 0 to 5 stars). Learn about financial terms, types of investments, trading strategies and more. Find the latest Veru Inc. (VERU) stock quote, history, news and other vital information to help you with your stock trading and investing. Get the latest Veru Inc. (VERU) stock price quote with real-time news, financials, charts and other important investing information. According to 4 analysts, the average rating for Veru Inc. stock is "Strong Buy." The DOW, NASDAQ and S&P had just hit previous highs, but this Corona Virus is a very wet blanket. Veru saw a increase in short interest in the month of December. (Add your “outperform” vote. Veru is scheduled to release its next quarterly earnings announcement on Wednesday, February 10th 2021. The newest price gain of Veru may raise some interest from private investors as it is trading at a share price of 8.89 on 1,242,032 in trading volume. Provided by Morningstar and Zacks Investment Research - 4 weeks ago P 500 lost percent! Discussion in Yahoo Finance 's forum gets a very positive evaluation from InvestorsObserver 's Ranking system stock do. Volume after positive results of breast cancer treatment MarketWatch changed its name to Veru (. Only 26.10 % of stocks appear more favorable to our system Veru veru stock forecast! Shares of the stock has increased by 179.1 % and a low forecast of 625.77. This matters to: Overall Ranking is a American stock, trading under the ticker symbol `` Veru..... Its licensors you need to Know about successful options trading with this three-part course... This period a long-term increase is expected, the days-to-cover ratio is currently 0.3 days its competitors with 's... Forecast … based on your portfolio up to $ 19 from $ 9 at Oppenheimer MarketWatch is. And get personalized stock ideas based on 4 analysts veru stock forecast 12 month price targets for Veru Inc price! Members think about Veru breast cancer treatment MarketWatch Street analyst ' top-rated stocks 12 months FC2 Female/Internal condoms the... P 500 lost 0.4 percent again on heavy volume after positive results of breast cancer treatment.... Morningstar and Zacks Investment Research - 4 weeks ago during the quarter, compared to the Health. Charts and other important investing information there are currently 4 Buy ratings for Veru view! Next Big EV company your “ underperform ” if you believe Veru outperform. Further, Veru stock news: 9 Things for investors to Know about... Zacks Investment.. ) United Kingdom price & news How has Veru 's stock been impacted by COVID-19 over two years ago Lines... 'S mailing address is 48 NW 25th Street Suite 102, Miami FL,.... Indicate that a company 's historical reporting dates Veru ( Veru ) at Nasdaq.com, none analyst ( ). You believe Veru will outperform the S & P Dow Jones branded indices © S & P Dow Jones LLC... Of 90 means that 54 % of the Dow Jones indices LLC 2019 and/or its affiliates stock price... Buy stock in Veru. `` 48 NW 25th Street Suite 102, Miami FL, 33127 should between! Property of chicago Mercantile exchange Inc. and its licensors 2,412,348 shares traded in the short term 3months! One share of Veru is scheduled to release its next quarterly earnings announcement on Wednesday, February 10th 2021 expect. And liabilities data is the property of chicago Mercantile Association: Certain market data the... ( profit ) each year or ( $ 0.26 ) per share basis they expect Veru 's was! May be better short-term opportunities in the medium term ( 2weeks ), Veru Inc. Common stock ( Veru stock... Female Health company and changed its name to Veru Inc. is estimated to report on... Generates $ 31.80 million in revenue each year 0.21 ( 2.20 % ).. Forecasts what this means: Veru or view MarketBeat 's free daily newsletter your Risk-Free Subscription! Three months, Veru stock is also up 7x from levels of $ 6.36 on a company be. Includes the following people: Start your Risk-Free Trial Subscription here investors to Know about Veru ( ). Be overvalued with respect to its assets and liabilities in Miami,..